E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/24/2004 in the Prospect News Convertibles Daily.

New Issue: ABN Amro sells $4.9 million 9% reverse exchangeables linked to Boston Scientific

By Caroline Salls

Pittsburgh, Nov. 24 - ABN Amro Bank NV priced $4.9 million of one-year 9% reverse exchangeables linked to Boston Scientific Corp. common stock, according to a 424B3 filing with the Securities and Exchange Commission.

Issuer:ABN Amro Bank NV
Issue:Reverse exchangeable senior medium-term notes
Underlying stock:Boston Scientific Corp.
Amount:$4.9 million
Maturity:Nov. 23, 2005
Coupon:9%
Price:Par
Payout at maturity:Smaller of par in cash or 29.394 shares of Boston Scientific stock
Exchange ratio:29.394
Exchange price:$34.02 (initial level of Boston Scientific stock)
Call:Non-callable
Pricing date:Nov. 19
Settlement date:Nov. 24
Lead manager:ABN Amro Financial Services
Distribution:Off shelf

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.